Cigna’s COVID-19 Global Impact Study shows early access to vaccine may create a brighter outlook
HONG KONG, Feb. 11, 2021 /PRNewswire/ — Cigna’s (NYSE:CI) International Markets business today published the fifth edition of its COVID-19 Global Impact Study, which highlights the contrast in well-being around the world as vaccine roll-out commenced for some, while other markets anticipated vaccine approvals to come. With the COVID-19 pandemic continually evolving and new waves and variants emerging in different geographies, these latest results show the initial impact of vaccine availability, and highlight a growing nostalgia for the normalcies of pre-pandemic way of life.
Building on the previous wave of results from October, which saw many markets reach record lows, this latest study was conducted in late November and early December 2020, and gauged global attitudes to five health indices – family, financial, physical, social and work. The study’s timing coincided with one…
— to www.prnewswire.co.uk